IHE – iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF (IHE) is a Health ETF, issued by iShares, $1.6B in assets, 0.41% expense ratio.
Returns as of Oct 23, 2026: 1 week +1.4%, 1 year +41.2%.
Tracks U.S. pharmaceuticals sector index, investing in manufacturers of prescription or over-the-counter drugs and vaccines.
Top holdings
- LLY – Eli Lilly and Company, 26.2%
- JNJ – Johnson & Johnson, 20.9%
- ZTS – Zoetis Inc, 4.9%
- VTRS – Viatris Inc, 4.6%
- PFE – Pfizer Inc, 4.6%
- RPRX – Royalty Pharma Plc, 4.6%
- MRK – Merck & Company Inc, 4.5%
- BMY – Bristol-Myers Squibb Company, 4.4%
- JAZZ – Jazz Pharmaceuticals PLC, 3.1%
- CORT – Corcept Therapeutics Incorporated, 2.5%
- ELAN – Elanco Animal Health, 2.4%
- AXSM – Axsome Therapeutics Inc, 1.5%
- LGND – Ligand Pharmaceuticals Incorporated, 1.3%
- DFTX – Definium Therapeutics, Inc., 1.1%
- INDV – Indivior PLC Ordinary Shares, 0.9%
- MANE – Veradermics, Incorporated, 0.9%
- AMRX – Amneal Pharmaceuticals, Inc. Class A Common Stock, 0.8%
- OGN – Organon & Co, 0.8%
- EWTX – Edgewise Therapeutics Inc, 0.7%
- AMLX – Amylyx Pharmaceuticals Inc, 0.6%
- TARS – Tarsus Pharmaceuticals Inc, 0.6%
- LQDA – Liquidia Technologies Inc, 0.6%
- ELVN – Enliven Therapeutics Inc., 0.6%
- SUPN – Supernus Pharmaceuticals Inc, 0.5%
- PBH – Prestige Brand Holdings Inc, 0.5%